U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Guideline Alliance (UK). Cerebral palsy in under 25s: assessment and management. London: National Institute for Health and Care Excellence (NICE); 2017 Jan. (NICE Guideline, No. 62.)

Cover of Cerebral palsy in under 25s: assessment and management

Cerebral palsy in under 25s: assessment and management.

Show details

21Assessment of pain and/or distress, discomfort and sleep disturbances

Review question: What is the validity and reliability of published tools to identify and aid the understanding of discomfort, pain and/or distress and sleep disturbances in children and young people with cerebral palsy?

21.1. Introduction

Children and young people with cerebral palsy may experience discomfort, pain and/or distress at different times. It is often difficult to recognise the signs and symptoms, especially in individuals with challenges in cognition and or communication. Recognition in a valid and reliable way helps the child or young person, their families and healthcare professionals to ensure appropriate support, care and intervention.

There are many comprehensive verbal and non-verbal tools that are used to assist in the understanding of discomfort, pain and/or distress for children and young people with cerebral palsy. It is vital that any tools used are indicative of the full spectrum of pain and distress across all levels of understanding.

The Committee considered that is was important to examine all the relevant evidence with an aim to determine the validity and reliability of commonly used tools to help recognise discomfort, pain and distress and understand how they may help in our understanding of the different components of pain that would help specific intervention and interdisciplinary support. A comprehensive history is essential as different approaches may be needed depending on the age, level of function, communication and cognitive ability to ensure appropriate assess to relevant services.

The aim of this review is to:

  • Assist parents, carers and healthcare professionals in the recognition of the clinical manifestation of pain, discomfort and distress in children and young people with cerebral palsy.
  • To provide guidance on reliable and valid tools used to identify pain in children and young people with cerebral palsy in the onward specialist referral and management for those children and young people with cerebral palsy who are experiencing discomfort, pain and distress.

21.2. Description of clinical evidence

Five studies reporting on validity and reliability of 4 pain tools have been included in this review (Breau 2002, Hunt 2004, Malviya 2006, Solodiuk 2010, Voepel-Lewis 2002). The tools are the Non-communicating Children’s Pain Checklist –- Postoperative Version (NCCPC-PV); the Paediatric Pain Profile (PPP); the Face, Llegs, Activity, Cry, Consolability Observational Tool (FLACC); the Individualised Numeric Rating Scale (INRS) and the Visual Analogue Scale (VAS).

Infants, children and young people with cerebral palsy aged up to 25 years were considered to be the target population for this review. However, no studies were found specifically on a cerebral palsy population and so the Committee considered for inclusion studies that looked at a mixed population of children and young people with neurodevelopmental disorders. The number of participants in each study varied, ranging from a minimum of 24 to a maximum of 140. Participants in the included studies ranged in age from 1 year to 19 years.

Three studies were undertaken in the USA: (Malviya 2006, Solodiuk 2010, Voepel-Lewis 2002); 1 was from the UK (Hunt 2004); 1 was from Canada (Breau 2002).

One study reported on validity and reliability of the NCCPC-PV (Breau 2002) in 24 nonverbal children with severe cognitive impairment, aged 3 to 19 years. One study validated the PPP (Hunt 2004) in 140 children with severe neurological and cognitive impairment, who were unable to communicate through speech or any augmentative device (43% had cerebral palsy). Two studies assessed validity and reliability of FLACC in 52 (Malviya 2006) and 79 (Voepel-Lewis 2002) children with cognitive impairment. One study reported on validity and reliability of the INRS in 50 nonverbal children with cognitive impairment (Solodiuk 2010).

With regards to the outcomes reported by the included studies, all 4 tools were tested for construct validity and interrater reliability.

No studies have been retrieved that reported on the other tools listed in the review protocol:

  • Tools that are designed to identify the presence of discomfort, pain or distress as reported by the patient or by proxy of the parent and/orcarer:
    • Wong-Baker FACES® Pain Rating Scale
    • Disability Distress Assessment Tool (DisDAT).
  • Tools that are designed to identify the presence of sleep disturbance as reported by the patient or by proxy of the parent and/or carer:
    • actigraphy
    • sleep diaries
    • polysomnography.

Given the aim of this review, validity designs were prioritised and the following were considered as the main criteria for assessing the quality of each study, as reported by Jerosch-Herold 2005:

  • sample size
  • sampling methodology
  • blinding of raters
  • statistical analysis.

For full details, see the review protocol in Appendix D. See also the study selection flow chart in Appendix F, study evidence tables in Appendix J and the exclusion list in Appendix K.

21.2.1. Clinical evidence profile

A summary of the studies that were included in this review is presented in Table 92.

Table 92. Summary of included studies.

Table 92

Summary of included studies.

21.3. Economic evidence

This review question is not relevant for economic analysis because it does not involve a decision between alternative courses of action.

No economic evaluations of tools to identify and aid understanding of discomfort, pain and/or distress were identified in the literature search conducted for this guideline. Full details of the search and economic article selection flow chart can be found in Appendix E and Appendix F, respectively.

21.4. Evidence statements

21.4.1. NCCPC-PV

One study validated the NCCPC-PV tool in 24 participants, reporting an inter-rater reliability of 0.82 and 0.78 before and after surgery, respectively. The study was limited by little sampling methodology information and small sample size.

21.4.2. PPP

One study validated the PPP tool in 140 participants, reporting an inter-rater reliability of 0.74, which was then 0.89 in a subgroup of participants who received analgesics. The study was limited by the heterogeneity in the variety and number of analgesia given to participants and because of the use of videotape to blind 1 set of observers.

21.4.3. FLACC

Two studies validated the FLACC tool in a total of 131 participants, reporting overall good reliability (ICC:0.90), with variation in exact agreement (35 to 94% for Face, Cry, Consolability and 17 to 77% for Legs). The study, however, used videotape to blind 1 set of observers to the administration of analgesia for the purposes of testing inter-rater reliability.

21.4.4. INRS

One study validated the INRS tool in 50 participants, reporting moderate to good reliability (ICC:0.65 to 0.80). The study was limited because data were collected over a period of several years and the sample size did not allow for extensive subgroup analysis.

21.5. Evidence to recommendations

21.5.1. Relative value placed on the outcomes considered

The aim of this review is to:

  • Assist parents, carers and healthcare professionals in the recognition of the clinical manifestation of pain, discomfort and distress in children and young people with cerebral palsy.
  • Provide guidance on reliable and valid tools used to identify pain in children and young people with cerebral palsy.
  • Assist in the onward specialist referral and management for those children and young people with cerebral palsy who are experiencing discomfort, pain and distress.

Validity and reliability of the tools were prioritised as critical outcomes for this review.

21.5.2. Consideration of clinical benefits and harms

There are numerous challenges in recognising the presence of pain, discomfort and distress in all children. This is even more apparent when a child or young person with cerebral palsy has cognitive or communication difficulties and patterns and behaviours associated with pain can present differently from the wider paediatric population.

Using tools such as pain questionnaires can help healthcare professionals and parents and/or carers to recognise appropriate behaviours and assess if pain, distress or discomfort is present. The Committee noted that pain, distress and/or discomfort can be expressed in various ways and may be impacted on by a variety of other factors such as psychological and emotional wellbeing, thirst, hunger and environmental stimulus. Additionally, as their primary advocate, parents and/or carers may be able to recognise pain from a child and young person’s cues and emotional distress and therefore play a major role in helping healthcare, education and social care professionals recognise and assess pain and discomfort.

The Committee agreed from the evidence presented that the Paediatric Pain Profile was the only tool that was validated for use in the post-operative settings. However, the Non-Communicating Children’s Pain Checklist (NCCPC-PV) and the Numeric Pain Rating Scale (INRS) were also reported in the papers as useful tools for assessing degree of pain, distress and discomfort. The Committee accepted that clinical practice was varied and that the identified studies were of low quality, however the most important factor was that pain, discomfort and distress was looked for. The Committee agreed that all healthcare professionals should regularly ask a child or young person with cerebral palsy regarding the presence of any pain, discomfort or distress. The Committee agreed that pain-assessment tools should be used, especially in children with no or limited communication, to help in the assessment. The Committee noted that regular reflection is necessary with regards to the presence, pattern and degree of pain as this can be challenging and can change over time. It was also noted that there is a subjective element to pain questionnaires used in noncommunicating children where healthcare professionals or parents and/or carers have the ability to quantify the qualitative signs of whether the child is in pain, distress and/or discomfort.

The Committee noted that recognising and assessing the presence and severity of pain, discomfort and/or distress needed not only the awareness of parents and/or carers but may also need onward referral to a specialist MDT for assessment of possible cause and ongoing management.

The Committee noted that no evidence was retrieved and there were no tools available for the routine recognition or assessment of sleep disturbances. However, based on their clinical experience they agreed that the use of simple measures such as sleep diaries to recognise sleep difficulties were appropriate to use in routine clinical practice, alongside the primary role of the parents and/or carers. Additionally, the Committee noted that sleep disturbances identified from the causes of pain and/or distress, discomfort and sleep disturbance evidence review (see section 20) were identified by sleep questionnaires and this reinforced their view that the use of sleep questionnaires was appropriate. They pointed out that more complex measures such as polysomnography and actinography were difficult to use in routine clinical practice, which would only be used when healthcare professionals think sleep disturbance is not because of pain or discomfort but because of sleep pathology.

The Committee noted that the use of pain-assessment tools in hospitals to help identify signs and symptoms of pain and discomfort in children and young people with cerebral palsy who cannot communicate had become widespread. However, the evidence based looking at their use in a community setting was very limited. The Committee agreed to develop and prioritise a research recommendation to assess the use of pain-assessment tools by parents and/or carers in a community setting.

21.5.3. Consideration of economic benefits and harms

Knowing the validity and reliability of published tools to identify and aid understanding of discomfort, pain and/or distress in children and young people with cerebral palsy may lead to better identification (and thus more timely management) in this population and has therefore, indirectly, potentially important resource implications. However, this review question is not relevant for economic analysis because it does not involve a decision between alternative courses of action.

21.5.4. Quality of evidence

The main reasons of bias in the included studies were small sample size, unclear sampling procedure and methods used to blind observers.

21.5.5. Other considerations

The Committee recognised that specialist services are not widely available or provided for assessment and management for pain and/or distress, discomfort and sleep distress for children and young people with cerebral palsy.

The recommendations related to this evidence review were based on the evidence and the Committee’s clinical experience.

21.5.6. Key conclusions

The Committee concluded that NCCPC-PV, PPP, FLACC, and INRS tools showed sufficient reliability to be used in a population of children and young people with neurodevelopmental disorders, including cerebral palsy. However, each of them has different characteristics with regards to the level of participation needed by parents and/or carers, time needed to complete the assessment, and the setting in which the tool was validated. Therefore these should be taken into consideration when deciding which tool to use.

21.6. Recommendations

89.

Refer the child or young person for a specialist multidisciplinary team assessment of pain discomfort, distress and sleep if the cause of these is not clear after routine assessment.

Pain, discomfort and distress

90.

Take into account that parents and familiar carers have a key role in recognising and assessing pain, discomfort and distress in children and young people with cerebral palsy.

91.

When assessing pain in children and young people with cerebral palsy:

  • recognise that assessing the presence and degree of pain can be challenging, especially if:
    • there are communication difficulties or learning disability (intellectual disability)
    • there are difficulties with registering or processing sensory information (see recommendations 117 and 118)
  • ask about signs of pain, discomfort, distress and sleep disturbances at every contact (see recommendations 87, 88, 94, 95 and 100 - 105)
  • recognise that pain-related behaviour can present differently compared with that in the wider population.

92.

Assess for other possible causes of distress in the absence of identifiable physical causes of pain and discomfort, such as:

  • psychological and emotional distress
  • increased sensitivity to environmental triggers
  • thirst or hunger.

93.

Consider using tools to identify pain or assess severity of pain in children and young people with cerebral palsy; for example:

  • For children and young people with communication difficulties:
    • Paediatric Pain Profile
    • Non-communicating Children’s Pain Checklist – postoperative version
  • For children and young people without communication difficulties:
    • Numeric pain rating scale.

Sleep disturbances

94.

When identifying and assessing sleep disturbances in children and young people with cerebral palsy:

  • recognise that parents and familiar carers have the primary role in this
  • consider using sleep questionnaires or diaries.

95.

Always ask about pain, sleep and distress as part of any clinical consultation.

21.7. Research recommendations

6.

Does use of pain assessment tools by parents or carers improve the recognition and early management of pain in children and young people with cerebral palsy in a community setting?

Table 93. Research recommendation rationale.

Table 93

Research recommendation rationale.

Table 94. Research recommendation statements.

Table 94

Research recommendation statements.

Copyright National Institute for Health and Care Excellence 2017.
Bookshelf ID: NBK533215

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (8.5M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...